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etraspanins CD9 and CD81 facilitate the fusion between
gametes, myoblasts, or virus-infected cells. Here, we
investigated the role of these tetraspanins in the fusion
of mononuclear phagocytes. Expression of CD9 and CD81
and their complex formation with integrins were up-regulated
when blood monocytes were cultured under normal con-
ditions. Under fusogenic conditions in the presence of Con A,
CD9 and CD81 up-regulation was inhibited, and their
complex formation with integrins was down-regulated.
Anti-CD9 and -CD81 antibodies, which were previously
shown to inhibit the fusion of gametes, myoblasts, and
virus-infected cells, unexpectedly promoted the fusion of
T
 
monocytes and alveolar macrophages. However, these
effects were not due to altered cell adhesion, aggregation,
or cytokine production. When stimulated in vitro or in
vivo, alveolar macrophages and bone marrow cells of
CD9- and CD81-null mice formed larger numbers of multi-
nucleated cells than those of wild-type mice. Finally, CD9/
CD81 double-null mice spontaneously developed multi-
nucleated giant cells in the lung and showed enhanced
osteoclastogenesis in the bone. These results suggest that
CD9 and CD81 coordinately prevent the fusion of mono-
nuclear phagocytes.
 
Introduction
 
The tetraspanin proteins comprise at least 28 distinct
members of transmembrane proteins that include CD9,
CD37, CD53, CD63, CD81, CD82, and CD151. All
these proteins share a characteristic structure that spans the
membrane four times and thereby forms two extracellular
loops. Tetraspanins complex with transmembrane proteins
such as CD4, CD8, CD19, CD21, CD46, major histo-
compatibility complex class I and II proteins, and integrins.
They also bind to intracellular signaling molecules including
phosphatidylinositol 4-kinase, phosphatases, and small
GTP-binding proteins. It is thought that, by facilitating
the formation of these multimolecular complexes, tet-
raspanins play roles in cell activation, proliferation, differ-
entiation, motility, fusion, and apoptosis (Boucheix and
Rubinstein, 2001).
Although their multifunctional characteristics and multi-
partnerships with other proteins have been increasingly re-
ported, the definitive biological functions of tetraspanins
still remain elusive. In this respect, studies of tetraspanin
knockout mice have revealed the cellular functions for which
a given tetraspanin is essential. One of these is a role of CD9
in gamete membrane fusion; CD9 knockout mice were
infertile because CD9-null eggs were incapable of fusing
with sperm (Miyado et al., 2000). Tetraspanins may play a
more general role in cell–cell fusion because additional reports
have implicated tetraspanins in other fusion events. Anti-
bodies against CD9 and CD81 inhibit the fusion of myo-
blasts, and CD9 transfection into myoblast-derived sarcoma
cells enhances syncytium formation (Tachibana and Hemler,
1999). Anti-CD81 and -CD82 mAbs perturb the fusion of
cells infected with human T cell leukemia virus type 1
(Fukudome et al., 1992). CD9 overexpression renders cells
more susceptible to feline immunodeficiency virus and canine
distemper virus, leading to elevated syncytium formation
(Löffler et al., 1997; Willett et al., 1997). These results suggest
that tetraspanins facilitate the fusion between gametes, myo-
blasts, and virus-infected cells. However, it is still unknown
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whether they play a similar role in cell fusion into other
multinucleated cells, such as multinucleated giant cells
(MGCs)* or osteoclasts.
Syncytia formed after the fusion of mononuclear phago-
cytes are called MGCs or osteoclasts. Multinucleation via
cell fusion appears to endow monocytes/macrophages with
the capacity to digest and resorb extracellular infectious
agents, foreign materials, and other components that are too
large to be internalized (Vignery, 2000). The presence of
MGCs is a hallmark of granulomas, which are formed in in-
flammatory sites of tuberculosis, fungal infection, HIV in-
fection, sarcoidosis, Crohn’s disease, and tumors (Anderson,
2000; James, 2000). The physiological meanings of MGCs
still remain unknown, but possible roles in the host defense
against bacterial infection have been suggested; MGCs may
limit the cell-to-cell spread of 
 
Mycobacterium tuberculosis
 
(Byrd, 1998) and may have stronger candidacidal activity
than macrophages (Enelow et al., 1992). Osteoclasts are
formed by the fusion of mononuclear progenitors of the
monocyte/macrophage lineage. These polykaryons are char-
acterized by the presence of tartrate-resistant acid phos-
phatase (TRAP) activity and have a crucial role not only in
physiological bone remodeling, but also in local bone disor-
ders such as osteoporosis and bone tumors. However, the ac-
tual cut-off line that discriminates between osteoclasts and
MGCs remains controversial (Vignery, 2000).
The mechanisms of the fusion of mononuclear phagocytes
are not well understood, but previous papers have shown
that several membrane proteins, such as CD44, CD47,
CD98, macrophage fusion receptor, P2X
 
7
 
 receptor, AD-
AMs, and integrins, are involved (Vignery, 2000; Namba et
al., 2001). In the present paper, we show that tetraspanins
CD9 and CD81 play a preventive role in the fusion of
mononuclear phagocytes.
 
Results
 
Con A modulates tetraspanin levels and integrin–
tetraspanin complex formation in monocytes
 
MGCs can be generated in vitro in different ways by stimu-
lating human blood monocytes or alveolar macrophages
with cytokines (Fais et al., 1994), phorbol myristate acetate
(Hassan et al., 1989), lectins (Chambers, 1977), condi-
tioned media (Abe et al., 1991), or mAbs (Tabata et al.,
1994). We isolated monocytes from human peripheral
blood and allowed them to attach to culture plate surfaces in
the presence of serum for 3 d, but the monocytes were not
able to fuse into MGCs. However, on stimulation with Con
A, cell–cell fusion occurred and many syncytia were formed
within 3 d of incubation (see following paragraph). We ex-
amined the expression of six tetraspanin proteins (CD9,
CD63, CD81, CD82, CD151, and NAG-2) by flow cy-
tometry, and confirmed that all of these tetraspanins except
NAG-2 were present on blood monocytes (unpublished
data). To analyze the expression in detail, the time courses of
CD9, CD63, and CD81 expression were examined by im-
munoblotting (Fig. 1 A). When blood monocytes were cul-
 
*Abbreviations used in this paper: 1
 
 
 
,25(OH)
 
2
 
D
 
3
 
, 1
 
 
 
,25-dihydroxyvita-
min D
 
3
 
; BAL, bronchoalveolar lavage; MGC, multinucleated giant cell;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;
sRANKL, soluble RANKL; TRAP, tartrate-resistant acid phosphatase.
Figure 1. Con A modulates tetraspanin levels and integrin–tetraspanin 
complex formation in monocytes. (A) Blood monocytes were cultured in 
the absence (left) or presence (right) of 10  g/ml Con A. After the indicated 
number of days, the cells were lysed with Brij99 lysis buffer. Whole-cell 
lysates containing equal amounts of protein were separated by SDS-PAGE 
and transferred to an Immobilon-P membrane. The membranes were blotted 
with anti-CD63 (AHN-16), anti-CD9 (MM2/57) plus anti-CD81 (M38), or 
anti-actin (C4) mAb. (B) Monocytes were lysed at d 0 or at d 3 in the 
absence or presence of Con A. Immunoprecipitations were performed with 
anti- 1 integrin (A-1A5), anti- 2 integrin (IB4), anti-CD9 (BU16), or anti-
CD81 (M38) mAb. Immunoprecipitated proteins were electrophoresed, 
transferred to membranes, and probed with anti-CD9 or -CD81 mAb (left). 
To confirm the presence of comparable amounts of each protein, whole-
cell lysates were blotted with anti-CD9, anti-CD81, anti- 1 (A-1A5), 
anti- 2 (MEM48), or anti-actin mAb (right).T
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tured under normal conditions, levels of CD9 and CD81
were up-regulated, reached a peak at 
 
 
 
2 d, and were sus-
tained until 3 d after incubation. CD63 also appeared to be
gradually up-regulated (Fig. 1 A, left). Notably, when
monocytes were cultured in the presence of Con A, the up-
regulation of CD9 and CD81 was inhibited compared with
that under normal conditions. In contrast, the up-regulation
of CD63 was enhanced in the presence of Con A (Fig. 1 A,
right). Control anti-actin blots showed that comparable
amounts of protein were loaded in each lane.
The up-regulation of tetraspanin–integrin complex forma-
tion during myoblast fusion has been reported (Tachibana
and Hemler, 1999). Among integrins, the 
 
 
 
1 subfamily most
commonly associates with tetraspanins, but a 
 
 
 
2 integrin,
 
 
 
L
 
 
 
2, also complexes with tetraspanins in hematopoietic
cells. Tetraspanins also form complexes with other tetraspan-
ins (Boucheix and Rubinstein, 2001). In freshly isolated
blood monocytes, CD9 and CD81 associated with 
 
 
 
1 and
 
 
 
2 integrins and with each other as shown in coimmunopre-
cipitation experiments (Fig. 1 B, left). During the culture un-
der normal conditions, the formation of tetraspanin–integrin
and CD9–CD81 complexes was up-regulated (compare d 3
with d 0, “–”). Notably, during multinucleation under fuso-
genic conditions containing Con A, the formation of tet-
raspanin–integrin complexes was instead down-regulated.
On the other hand, the up-regulation of the CD9–CD81
complex formation was not affected by the presence of Con
A (compare d 3 with d 0, “Con A”). In control immunoblot-
Figure 2. Anti-CD9 and -CD81 mAbs promote the fusion of blood monocytes. (A) Blood monocytes were induced to fuse into MGCs in 
culture medium containing 10  g/ml Con A for 3 d in the absence or presence of 10  g/ml of the indicated mAbs. Nuclei were then visualized 
using Wright stain. Bar, 250  m. (B) Monocytes (2   10
5) were plated into the wells of a 96-well tissue culture plate and induced to fuse in 
the absence or presence of 10  g/ml of the indicated mAbs. Fusion rates were determined by calculating the percentages of the number of 
nuclei within MGCs (three or more nuclei per cell) per total number of nuclei. (C) Monocytes were induced to fuse in the absence or presence 
of increasing concentrations of anti-CD9 (BU16), anti-CD81 (JS64) mAbs, or isotype-matched IgG, and then fusion rates were determined. 
(D) Monocytes were induced to fuse in the absence or presence of 10  g/ml of the indicated mAbs (in the case of BU16   JS64, 10  g/ml of 
each was used). Fusion rates were then determined. Each bar and data point represent the mean   SD.T
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ting using whole-cell lysates (Fig. 1 B, right), the up-regula-
tion of CD9 and CD81 under normal conditions was con-
firmed as already shown in Fig. 1 A. The presence of Con A
inhibited this up-regulation, but even under these condi-
tions, higher levels of CD9 and CD81 appeared at d 3 com-
pared with the level at d 0. The expression of 
 
 
 
1 and 
 
 
 
2 inte-
grins was not much affected by these culture conditions.
Thus, the down-regulation of CD9 and CD81 in 
 
 
 
1 or 
 
 
 
2
immunoprecipitates under fusogenic conditions was not due
to the reduction of total CD9, CD81, 
 
 
 
1, or 
 
 
 
2 proteins.
 
Anti-CD9 and -CD81 mAbs promote the fusion of 
blood monocytes/alveolar macrophages
 
Anti-CD9 and -CD81 antibodies were previously shown to
inhibit the fusion of sperm and egg (Takahashi et al., 2001),
myoblasts (Tachibana and Hemler, 1999), or virus-infected
cells (Fukudome et al., 1992; de Parseval et al., 1997). To ex-
amine the role of tetraspanins in monocyte fusion, we added
anti-tetraspanin mAbs to the monocyte culture under fuso-
genic conditions containing Con A. Unexpectedly, anti-CD9
(BU16) and anti-CD81 (JS64) mAbs dramatically promoted
monocyte fusion (Fig. 2). The fusion rates in the presence of
BU16 and JS64 were elevated 3.5-fold and fourfold relative
to those in control IgG cultures, respectively. Moreover,
MGCs formed in the presence of these mAbs were larger in
size than the control MGCs (Fig. 2 A). Another anti-CD9
mAb, MM2/57, also promoted the fusion, although its effect
was weaker than those of BU16 and JS64. On the other
hand, anti-CD14, -CD63, and -CD151 mAbs had little, if
any, fusion-promoting effects. Anti-integrin 
 
 
 
1 and 
 
 
 
2 mAbs
significantly inhibited the fusion (Fig. 2, A and B), consistent
 
with previous reports (Most et al., 1990; Tabata et al., 1994).
To examine the dose dependency, fusion rates in the presence
of various concentrations of BU16, JS64, and isotype-
matched IgG were determined (Fig. 2 C). The fusion-pro-
moting effects of BU16 and JS64 were dose dependent,
reached a plateau at 1–10 
 
 
 
g/ml, and decreased slightly at 20
 
 
 
g/ml. Meanwhile, the isotype-matched control IgG had lit-
tle effect on monocyte fusion even at 20 
 
 
 
g/ml. To exclude
the possibility that the effects of BU16 and JS64 were medi-
ated by Fc receptors, we generated divalent F(ab
 
 
 
)
 
2
 
 fragments
and examined their effects on monocyte fusion. As shown in
Fig. 2 D, these F(ab
 
 
 
)
 
2
 
 fragments exerted similar degrees of
fusion-promoting effects as untreated mAbs. Finally, the
coaddition of anti-CD9 and -CD81 mAbs appeared to have
additive effects on the monocyte fusion (Fig. 2, A and D).
Next, we isolated alveolar macrophages from human lungs
and examined the effects of these mAbs on the fusion of
these cells. Like blood monocytes, alveolar macrophages
were capable of fusing into MGCs in response to stimula-
tion by Con A. Anti-CD9 and -CD81 mAbs enhanced the
fusion of alveolar macrophages as well as that of blood
monocytes. In contrast, anti-integrin 
 
 
 
1 and 
 
 
 
2 mAbs in-
hibited their fusion (unpublished data).
 
Anti-CD9 and -CD81 mAbs do not affect cell adhesion, 
aggregation, proliferation, or cytokine production
 
The effects of anti-CD9 and -CD81 mAbs may have been
due to altered cell adhesion or aggregation, both of which
are prerequisite for cell–cell fusion. To examine these possi-
bilities, we performed adhesion and aggregation assays. As
shown in Fig. 3 A, anti-
 
 
 
1 and -
 
 
 
2 mAbs significantly in-
Figure 3. Anti-CD9 and -CD81 mAbs do not affect monocyte adhesion or aggregation. (A) Blood monocytes (2   10
5) were suspended in 
RPMI 1640 containing 10  g/ml Con A, and were allowed to adhere to the wells of a 96-well culture plate for 12 h in the absence or presence 
of 10  g/ml of the indicated mAbs. Nonadherent cells were removed, and the remaining adherent cells were evaluated using an MTT assay. 
(B) Monocytes (2   10
5) were cultured in RPMI 1640 containing 5  g/ml Con A in the absence or presence of 10  g/ml mAbs for 12 h on the 
wells of a 96-well nontissue culture-treated plate. The numbers of cell aggregates ( 4 cells/aggregate) were determined under a light micro-
scope. Each bar represents the mean   SD.T
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hibited monocyte adherence to the tissue culture–treated
surfaces. This is consistent with a previous report showing
that 
 
 
 
1 and 
 
 
 
2 integrins mediate adhesion to culture sur-
faces during macrophage fusion (McNally and Anderson,
2002). Meanwhile, anti-CD9 and -CD81 mAbs, and con-
trol IgG had no effect on the monocyte adherence. In aggre-
gation assays, no mAb had a significant effect on the mono-
cyte aggregation that was induced by 10 
 
 
 
g/ml Con A
(unpublished data). However, when a lower concentration
of Con A (5 
 
 
 
g/ml) was used, anti-
 
 
 
2 integrin mAbs mark-
edly inhibited the monocyte aggregation (Fig. 3 B). On the
other hand, neither anti-
 
 
 
1 integrin mAb, anti-CD9 and
-CD81 mAbs, anti-CD14 mAb, nor control IgG affected
the monocyte aggregation. We also examined whether anti-
CD9 and -CD81 mAbs alter the proliferation of monocytes
using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT) assay, and observed that these mAbs
had no effect on monocyte proliferation (unpublished data).
Previous reports suggested that activated macrophages se-
crete cytokines such as tumor necrosis factor-
 
 
 
 (TNF-
 
 
 
), IL-
1
 
 
 
, and IL-6, and that these cytokines play an important role
in MGC formation (Anderson, 2000). Accordingly, we inves-
tigated whether anti-CD9 and -CD81 mAbs affect the pro-
duction of these cytokines by Con A–stimulated monocytes.
Blood monocytes were cultured for 3 d with Con A in the ab-
sence or presence of mAbs, and then the concentrations of
TNF-
 
 
 
, IL-1
 
 
 
, and IL-6 in culture supernatants were deter-
mined using enzyme-linked immunosorbent assays. The su-
pernatants of monocytes cultured without Con A (normal
conditions) were also examined in parallel. As compared with
normal conditions, Con A remarkably enhanced the produc-
tion of these cytokines by monocytes. The up-regulation of
TNF-
 
 
 
, IL-1
 
 
 
, and IL-6, was 23-, 59-, and 48-fold, respec-
tively (380 to 8730 pg/ml for TNF-
 
 
 
, 50 pg/ml to 2970 pg/
ml for IL-1
 
 
 
, and 230 pg/ml to 10980 pg/ml for IL-6). The
presence of anti-tetraspanin, integrin, or control mAbs had no
significant effect on this up-regulation (unpublished data).
 
Soluble GST–CD9 large extracellular loop protein 
inhibits monocyte fusion
 
There was a possibility that the results of the antibody-
blocking experiments were caused by steric hindrance to
molecules adjacent to the tetraspanins. Thus, to extend the
observations made in the antibody experiments, we studied
effects of a recombinant GST fusion protein that contained
the large extracellular loop of human CD9 (GST–CD9;
Shimizu et al., 2002). Various concentrations of GST–CD9
were added to the monocyte culture under fusogenic condi-
tions containing Con A. As shown in Fig. 4, GST–CD9 in-
hibited monocyte fusion, and this inhibitory effect was dose-
dependent in the range of 0.2–20 
 
 
 
g/ml. On the other
hand, neither GST alone nor GST–murine CD9 fusion pro-
tein (GST–mCD9) had significant fusion-inhibitory effect
even at 20 
 
 
 
g/ml.
 
Anti-CD9 and -CD81 mAbs promote the fusion of 
murine alveolar macrophages and bone marrow cells
 
To further extend our observations on cell fusion of the
monocyte/macrophage lineage, murine alveolar macrophages
were isolated by bronchoalveolar lavage (BAL) and in-
duced to fuse into MGCs by the addition of 1
 
 
 
,25-dihy-
droxyvitamin D
 
3
 
 (1
 
 
 
,25(OH)
 
2
 
D
 
3
 
) and culture supernatants
of Con A–stimulated spleen cells as described previously
(Abe et al., 1983). We performed an immunofluorescence
study because CD9 protein on murine alveolar macrophages
was resistant to fixation and permeabilization procedures. As
compared with control IgG (Fig. 5 A), staining of CD9 was
positive in freshly isolated murine alveolar macrophages
(Fig. 5 B), and it was up-regulated after 3 d of incubation
under normal culture conditions, especially at the cell pe-
riphery and cell–cell contacts (Fig. 5 C). Conversely, fuso-
genic culture conditions appeared to inhibit this CD9 up-
regulation (Fig. 5 D). CD9 expression was relatively weak in
unfused macrophages and MGCs, and its distribution was
more obvious at the perinuclear region than at the cell pe-
riphery in MGCs (Fig. 5 D, inset). The findings of immu-
noblotting were consistent with those of the immunofluo-
rescence. Up-regulation of CD9 was observed under the
normal culture conditions, whereas the fusogenic conditions
suppressed this up-regulation (Fig. 5 E).
To examine the effects of anti–mouse tetraspanin mAbs,
anti–mouse CD9 and CD81 mAbs were added to murine al-
veolar macrophages under fusogenic conditions. Because mu-
rine alveolar macrophages formed smaller numbers of MGCs
than human monocytes/macrophages, we evaluated their fu-
sion by determining the numbers of MGCs instead of fusion
rates. As shown in Fig. 6, anti–mouse CD9 and CD81 mAbs
promoted the fusion of murine macrophages. Moreover, the
combination of anti-CD9 and -CD81 mAbs exerted an addi-
tive effect. The effect of anti-CD9 mAb, KMC8, was not me-
diated by Fc portion–Fc receptor interaction, because the
F(ab
 
 )2 fragments exerted a quite similar effect (Fig. 6 B).
Figure 4. Soluble GST–CD9 large extracellular loop protein 
inhibits monocyte fusion. Blood monocytes were induced to fuse 
into MGCs in culture medium containing Con A for 3 d in the 
absence or presence of the indicated concentrations of GST, GST–
mCD9, or GST–CD9. Fusion rates were then determined. A higher 
concentration (15  g/ml) of Con A was used in order to show the 
dose-dependent, fusion-inhibitory effect of GST–CD9. Each bar 
represents the mean   SD.T
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Next, we examined the effects of anti–mouse CD9 and
CD81 mAbs in the fusion of osteoclast progenitor cells. Mu-
rine bone marrow cells were isolated from tibiae and in-
duced to fuse by the addition of soluble RANKL (sRANKL)
and M-CSF (Li et al., 2002). Like alveolar macrophages, the
addition of these mAbs promoted the fusion of bone mar-
row cells. Relative to control IgG, numbers of TRAP-posi-
tive multinucleated cells in the presence of anti-CD9 mAb
(KMC8) and anti-CD81 mAb (2F7) increased fourfold and
twofold, respectively (unpublished data).
Enhanced cell fusion by CD9- and CD81-null alveolar 
macrophages and bone marrow cells after in vitro or in 
vivo stimulation
To determine more definitively the roles of CD9 and CD81
in monocyte/macrophage fusion, we investigated MGC for-
mation of CD9- and CD81-deficient murine alveolar mac-
rophages. Alveolar macrophages were isolated by BAL from
the lungs of wild-type, CD9-null, and CD81-null mice, but
no MGCs were present in these mice (unpublished data).
Equal numbers of collected macrophages were then induced
to fuse into MGCs in vitro. Notably, after the stimulation,
CD9 ( / ) and CD81 ( / ) alveolar macrophages formed
threefold and fourfold more MGCs than wild-type macro-
phages, respectively (Fig. 7 A). To further examine if the defi-
ciency of CD9 or CD81 alters MGC formation in vivo, we
used a Propionibacterium acnes–induced lung inflammation
Figure 5. Modulation of the expression and distribution of CD9 
in murine alveolar macrophages under fusogenic conditions. 
Murine alveolar macrophages were cultured in DME containing 5% 
human serum for 3 d under normal conditions (C) or fusogenic 
conditions containing 1 ,25(OH)2D3 and culture supernatant from 
Con A–stimulated splenocytes (D). Macrophages were immuno-
stained at d 0 (A and B) and at d 3 (C and D) with control mAb (A) 
or anti-CD9 mAb (B–D). Cells and nuclei were visualized with 
FITC-conjugated anti–rat immunoglobulin and propidium iodide. 
Typical CD9 distribution in an MGC is shown in the inset. Bar, 250 
 m (100  m for the inset). (E) Murine alveolar macrophages were 
cultured in the absence or presence of 1 ,25(OH)2D3 and super-
natant (SN) from Con A–stimulated splenocytes. After the indicated 
number of days, cells were lysed, and whole-cell lysates containing 
equal amounts of protein were separated by SDS-PAGE, transferred 
to a membrane, and probed with anti-CD9 mAb (KMC8).
Figure 6. Anti-CD9 and -CD81 mAbs promote the fusion of murine 
alveolar macrophages. (A) Murine alveolar macrophages were 
induced to fuse into MGCs under fusogenic conditions containing 
1 ,25(OH)2D3 and culture supernatant from Con A–stimulated 
splenocytes for 3 d in the absence or presence of 10  g/ml of 
the indicated mAbs. Nuclei were then visualized using Wright stain. 
Bar, 250  m. (B) Murine alveolar macrophages (3   10
5) were 
plated into the wells of a 96-well culture plate and induced to fuse 
in the absence or presence of 10  g/ml control IgG or various anti-
CD9 and -CD81 mAbs (in the case of KMC8   2F7, 10  g/ml of 
each was used). The numbers of MGCs per well were determined. 
Each bar represents the mean   SD.T
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model (Itakura et al., 2001). Wild-type and mutant mice
were challenged by intratracheal injection of heat-killed P.
acnes. After 7 d, lung paraffin sections were prepared and an-
alyzed to detect MGCs. Although infiltration of inflamma-
tory cells consisting of neutrophils, macrophages, and lym-
phocytes into the alveolar space was reported  3 d after P.
acnes injection (Itakura et al., 2001), most of cells remaining
at d 7 were macrophages. Remarkably, although few MGCs
were present in wild-type mice, substantial numbers of
MGCs were formed in the airspace of CD9- and CD81-null
mice (Fig. 7 B, left). In a separate experiment to quantify the
MGC formation, alveolar macrophages were separated by
BAL after P. acnes injection, and the number of MGCs was
determined (Fig. 7 B, right). The total numbers of cells iso-
lated from wild-type and mutant mice were not significantly
different (unpublished data), but nonetheless, sixfold and
threefold more MGCs were detected in CD9- and CD81-
null mice compared with wild-type mice, respectively.
We also isolated bone marrow cells from wild-type, CD9-
null, and CD81-null mice and induced these cells to fuse in
Figure 7. Enhanced cell fusion by CD9- and CD81-null murine alveolar macrophages and bone marrow cells after in vitro or in vivo 
stimulation. (A) Alveolar macrophages (3   10
5) from wild-type, CD9 ( / ), and CD81 ( / ) mice were plated into the wells of a 96-well 
culture plate and induced to fuse into MGCs by a 3-d incubation with 1 ,25(OH)2D3 and splenocyte-conditioned medium. Nuclei were then 
visualized using Wright stain (left). The numbers of MGCs per well were determined (right). (B) 300  g heat-killed P. acnes was administered 
intratracheally to wild-type, CD9 ( / ), and CD81 ( / ) mice. After 7 d, lung paraffin sections were stained with hematoxylin and eosin (left). 
Arrowheads indicate MGCs. In a separate experiment, alveolar macrophages were isolated by BAL from the lung, and the numbers of MGCs 
per lung were determined (right). Assays were done in triplicate for each animal tested. Two additional experiments gave similar results. 
(C) Bone marrow cells (2   10
6) from wild-type, CD9 ( / ), and CD81 ( / ) mice were plated into the wells of a 24-well culture plate and 
induced to fuse by a 7-d incubation with sRANKL and M-CSF. Cells were then stained for TRAP (left). The numbers of TRAP-positive multi-
nucleated cells (MNCs) per well were determined (right). Bar, 100  m (A–C). Each bar represents the mean   SD.T
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vitro by the addition of sRANKL and M-CSF. TRAP-posi-
tive multinucleated cells generated from CD9- and CD81-
null marrow cells were larger in size and increased sixfold
and twofold in number, respectively, compared with those
from wild-type marrow cells (Fig. 7 C).
CD9/CD81 double-null mice spontaneously develop 
MGCs in the lung and showed enhanced 
osteoclastogenesis in the bone
Because CD9 and CD81 appear closely related in view of
amino acid sequence (the identity in the aligned human se-
quences is  31%; Boucheix and Rubinstein, 2001), one
may compensate for the function of the other in CD9
or CD81 single-null mice. Therefore, we generated CD9/
CD81 double-null mice by intercrossing CD9 ( / )/
CD81 ( / ) mice. CD9/CD81 double-null mice were via-
ble, but smaller in size than wild-type mice and displayed os-
teopenic phenotype in association with angular kyphotic de-
formity of the spine (unpublished data). Fig. 8 shows
hematoxylin- and eosin-stained lung sections and TRAP-
stained bone sections from wild-type and double mutant
mice. Notably, alveolar airspace enlargement with the infil-
tration of macrophages and a smaller number of lympho-
cytes into the space and septa was observed in CD9/CD81
double-null mice (Fig. 8, B and C). More importantly, al-
though no MGCs were detected in wild-type (Fig. 8 A) or
CD9 ( / )/CD81 ( / ) mice (unpublished data), eosin-
stained MGCs were spontaneously formed in the alveolar
space of double mutant mice (Fig. 8, B and C). Most of
these MGCs were large, round, eosin-stained cells contain-
ing 3 to  10 nuclei, and resembled those detected in CD9
or CD81 single-null mice that had been stimulated by in-
tratracheal injection of P. acnes (Fig. 7 B). Few neutrophils
or eosinophils were present, thus ruling out the occurrence
of bacterial or parasitic infection. Findings from bones of
CD9/CD81 double-null mice were also remarkable (Fig. 8
E). When compared with the wild-type (Fig. 8 D) and sin-
gle-null littermates, TRAP-positive osteoclasts in tibiae in-
creased 1.5-fold in number per millimeter bone surface
(wild type, 1.78   0.19/mm; CD9 ( / ) mice, 1.79  
0.70/mm; CD81 ( / ) mice, 1.67   0.22/mm; CD9 ( /
 )/CD81 ( / ) mice, 2.61   0.29/mm; P   0.005 versus
wild type in the t test, n   4). Dual-energy X-ray absorpti-
ometry on femurs showed that bone-mineral density of
double mutant mice were significantly reduced (wild-type,
25.1   1.8 mg/cm
2; CD9 ( / ) mice, 26.1   0.4 mg/cm
2;
CD81 ( / ) mice, 25.5   1.7 mg/cm
2; CD9 ( / )/
CD81 ( / ) mice, 22.0   1.5 mg/cm
2; P   0.05 versus
the wild type).
Discussion
To induce fusion between monocytes in vitro, we used cul-
tures containing Con A, because Con A readily induces
monocyte fusion in a dose- and time-dependent manner
(Takashima et al., 1993). A time-course analysis based on
immunoblotting revealed that the up-regulation of the
CD63 level was moderate under normal culture conditions,
whereas stronger elevation of CD63 was observed under fu-
sogenic conditions containing Con A. On the other hand,
although CD9 and CD81 were up-regulated under normal
conditions, their up-regulation was rather inhibited under
fusogenic conditions. The findings of immunofluorescence
and immunoblotting analysis of murine alveolar macro-
phages were in line with this. CD9 distribution into the cell
periphery and cell–cell contacts was less marked under fuso-
Figure 8. Histological sections of the lung and bone from wild-type and CD9/CD81 double-null mice. Lung sections from wild-type (A) 
and CD9 ( / )/CD81 ( / ) mice (B and C) aged 8 wk were stained with hematoxylin and eosin. Bone sections of the proximal tibia from 
wild-type (D) and CD9 ( / )/CD81 ( / ) mice (E) were stained for TRAP. Arrowheads indicate typical MGCs (B and C) and osteoclasts 
(D and E). Bars: 250  m for A and B, 100  m for C–E.T
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genic conditions. Moreover, CD9 staining was more obvi-
ous at the perinuclear area than at the cell periphery in
MGCs. Consistent with these findings, a recent paper re-
ported CD9 down-regulation in murine peritoneal macro-
phages stimulated with IFN- , which is a cytokine capable
of promoting fusion of macrophages (Wang et al., 2002).
These results suggest that the functions of CD9 and CD81
may be suppressed under fusogenic conditions, and that the
functional contribution of these tetraspanins to monocyte/
macrophage fusion might be different from that of CD63.
All of anti-tetraspanin mAbs used in fusion assays of the
present work were previously shown to inhibit cellular func-
tions in vitro. In particular, the anti–human CD9 mAbs
MM2/57 and BU16 were reported to inhibit virus-induced
fusion (Löffler et al., 1997). The anti–mouse CD9 mAbs
KMC8 and JF9 were reported to prevent sperm–egg fusion
(Miyado et al., 2000; Takahashi et al., 2001). KMC8 and
anti–mouse CD81 mAb 2F7 inhibited/delayed the fusion of
the myoblast cell line C2C12 (Tachibana and Hemler,
1999). These anti-CD9 and -CD81 mAbs unexpectedly
promoted the fusion of mononuclear phagocytes. It is un-
likely that the effects were mediated by Fc portion–Fc recep-
tor interactions, because isotype-matched control IgG had
no effect on the fusion, and F(ab )2 fragments had similar ef-
fects to untreated mAbs. These results raise the possibility
that CD9 and CD81 facilitate the fusion of virus-infected
cells, sperm–egg, and myoblasts, while preventing the fusion
of monocytes/macrophages via the same epitopes. A previ-
ous work used a soluble GST–CD81 extracellular loop fu-
sion protein to demonstrate that this protein bound to
neurons but not to astrocytes, and that it blocked neuron-
induced astrocyte proliferative arrest, thus suggesting the
presence of a ligand for CD81 on neurons (Kelic et al.,
2001). In the present work, the GST–CD9 extracellular
loop fusion protein inhibited monocyte fusion in a dose-
dependent manner. This result further supports the involve-
ment of CD9 protein in monocyte fusion, and may reflect a
functional interaction between the CD9 extracellular loop
and its putative ligand on an apposed cell surface.
With regard to genuine tetraspanins (Boucheix and Ru-
binstein, 2001), mice lacking CD9 (Miyado et al., 2000),
CD37 (Knobeloch et al., 2000), CD81 (Maecker and Levy,
1997; Miyazaki et al., 1997), and Tssc6 (Tarrant et al.,
2002) have been produced by gene targeting. CD9-null
mice are infertile due to defective fusion capacity of their
eggs. CD81-null mice are deficient in T cell–dependent IgG
production and in Th2 cytokine secretion (Maecker et al.,
1997). Recently, CD81-null mice were also reported to have
reduced reproductive capacity after repeated backcrosses
(Deng et al., 2000). Moreover, exogenously overexpressed
CD81 rescued the fusibility of CD9-null eggs (Kaji et al.,
2002). Thus, CD9 and CD81 may share an essential role in
gamete fusion processes. Meanwhile, no abnormal findings
in other cell fusion events and no morphological abnormali-
ties have been reported in tetraspanin knockout mice. How-
ever, given that several different tetraspanins form com-
plexes with each other, the loss of a particular tetraspanin
may be compensated by other tetraspanins. We presumed
that single tetraspanin knockout mice under particular con-
ditions or multiple tetraspanin knockout mice may reveal
novel tetraspanin functions. In fact, in the present work, in
response to in vitro and in vivo stimulation, CD9- and
CD81-null macrophages and bone marrow cells displayed
enhanced fusion capacity. Furthermore, CD9/CD81 dou-
ble-null mice spontaneously developed MGCs in the lung
and showed increased osteoclastogenesis in the bone. It is
tempting to presume that osteopenic phenotype of CD9/
CD81 double-null mice is due to enhanced osteoclastogene-
sis. However, bone mass is maintained under a balance be-
tween bone resorption and formation. In fact, CD9 is
present on osteoblast progenitors, and this CD9 molecule is
also likely to be involved (Hayashi et al., 2000). Thus, de-
tailed morphometric analysis and studies to evaluate the ac-
tivities of osteoclasts and osteoblasts are obviously required
to elucidate mechanisms in the osteopenic phenotype; such
studies are currently in progress. Collectively, our data ob-
tained using mAb and knockout mouse experiments suggest
that CD9 and CD81 function to inhibit the fusion of
mononuclear phagocytes, and that these tetraspanins may be
able to compensate for each other.
Because the roles of CD9 and CD81 in monocyte/mac-
rophage fusion proposed based on the present paper are con-
tradictory to the previous hypothesis that these tetraspanins
facilitate cell–cell fusion, the mechanisms of the tetraspanin
contribution to cell–cell fusion now appear to be complex.
One possible reason for this may be that the functions of tet-
raspanins are dependent on the cell lineage. Notably, al-
though lectins such as Con A and phytohemagglutinin in-
duce the fusion of macrophages, these lectins paradoxically
inhibit the fusion of virus-infected cells, myoblasts, and ga-
metes (Chambers, 1977). This evidence may indicate a fun-
damental distinction between macrophage and nonmac-
rophage cell fusion.
Integrins are well known to form complexes with tet-
raspanins, and tetraspanins may modulate the adhesive func-
tions of integrins during cell–cell fusion (Boucheix and Ru-
binstein, 2001). In fact, it was shown in previous papers that
the fusion of blood monocytes involves  1 and  2 integrins
(Most et al., 1990; Tabata et al., 1994). In the present work,
both anti- 1 and - 2 integrin mAbs inhibited the fusion of
monocytes, probably due to blocking of monocyte adher-
ence and aggregation, respectively. However, these adhesive
and aggregative functions are not likely to be modified by
tetraspanins because neither anti-CD9 nor anti-CD81 mAb
altered monocyte adhesion or aggregation. We also observed
that  1 and  2 integrins were complexed with CD9 and
CD81 in freshly isolated blood monocytes, and this complex
formation was up-regulated under normal culture condi-
tions. Complexes between CD9 and CD81 were also in-
creased; these up-regulations may at least partly reflect the
elevated levels of total CD9 and CD81 proteins, but are
consistent with the previous report that CD9 and  1 inte-
grins assemble into a molecular complex during maturation
of monocytes (Kurita-Taniguchi et al., 2001). However,
under fusogenic conditions, the complex formation of tet-
raspanin (CD9 or CD81)–integrin ( 1 or  2) was down-
regulated, whereas tetraspanin–tetraspanin (CD9–CD81)
complex formation occurred normally. A mild detergent
(Brij99) was used in coimmunoprecipitation experiments,
indicating that the molecular complexes in cell lysates couldT
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be part of raft-like membrane microdomains (Claas et al.,
2001). Possibly, the different regulation of tetraspanin–inte-
grin and tetraspanin–tetraspanin complexes might reflect
differential localization of these complexes into distinct mi-
crodomains. Further studies will be needed to clarify the
contribution of tetraspanin–integrin complexes to mono-
cyte/macrophage fusion.
Other proteins involved in the fusion of mononuclear
phagocytes, such as ADAMs (Namba et al., 2001), CD44,
CD47 (Vignery, 2000), and CD98 (Tabata et al., 1994),
may be affected by CD9 and CD81. An interaction between
CD9 and ADAMs was suggested in the fusion between
sperm and eggs (Zhu and Evans, 2002). Both CD44 and
CD47 were reported to associate with CD9 (Jones et al.,
1996; Longhurst et al., 1999). CD98 associates with  1 in-
tegrins and is important in integrin activation (Fenczik et
al., 2001). Tetraspanins may indirectly influence CD98
function through their participation in integrin complexes.
Roles of these proteins in tetraspanin-regulated monocyte/
macrophage fusion remains unknown, but the fact that
CD9 associates with multiple monocyte/macrophage fusion-
related proteins further supports the involvement of tet-
raspanins in this particular type of fusion.
In conclusion, the present paper has demonstrated a novel
fusion-regulatory function of tetraspanins. While facilitating
the fusion of gametes, myoblasts, and virus-infected cells,
CD9 and CD81 are essential to prevent the fusion of mono-
nuclear phagocytes. Given that multinucleation endows cells
with more resorptive capacity for extracellular components
such as bone or infectious agents (Vignery, 2000), functional
alterations of tetraspanins may contribute to the progression
of osteoporosis, infection, and granulomatous diseases.
Materials and methods
Antibodies and reagents
Mouse anti-CD9 mAbs (BU16 and MM2/57), anti-CD81 mAb (JS64),
and anti-CD63 mAb (AHN-16) were purchased from Biodesign, Bio-
source International, Immunotech, and CHEMICON International, re-
spectively. Mouse mAb against CD81 (M38) was a gift from Dr. O.
Yoshie (Kinki University School of Medicine, Osaka, Japan). Mouse
mAb against CD151 (5C11) and mouse anti- 1 integrin mAbs (A-1A5
and SG/19) were described previously (Berditchevski et al., 1995;
Tachibana et al., 1996; Yoch et al., 1998). Another mouse anti- 1 integrin
mAb (4B4) was obtained from Beckman Coulter. Mouse anti- 2 integrin
mAbs (IB4, MEM48, YFC118.3, and TS1/18) were purchased from An-
cell, Monosan, CHEMICON International, and Endogen, respectively.
Rat anti–mouse CD9 mAb (KMC8) and anti-CD81 mAb (Eat1) were ob-
tained from BD Biosciences. Hamster anti–mouse CD81 mAb (2F7) was
purchased from Southern Biotechnology Associates, Inc. Rat anti–
mouse CD9 mAb (JF9) was provided by Dr. P.W. Kincade (Oklahoma
Medical Research Foundation, Oklahoma City, OK). F(ab )2 fragments of
several mAbs were prepared using an ImmunoPure
® F(ab )2 preparation
kit (Pierce Chemical Co.). Preparation of a recombinant GST fusion pro-
tein containing the large extracellular loop of CD9 was described previ-
ously (Shimizu et al., 2002). A GST fusion protein containing murine
CD9 large extracellular loop residues 111–192 (GST–mCD9) was pro-
duced in the Mekada laboratory.
Isolation of blood monocytes, alveolar macrophages, 
and bone marrow cells
Peripheral blood mononuclear cells were isolated from heparinized whole
blood by Ficoll-Hypaque density gradient centrifugation. Mononuclear
cells were collected and cultured on MSP plates (Japan Immunoresearch).
The adherent monocytes were detached and suspended in RPMI 1640 me-
dium containing 10% heat-inactivated FCS, 100 U/ml penicillin, and 100
 g/ml streptomycin (culture medium). Human alveolar macrophages were
collected by BAL from patients in Osaka University Hospital (Osaka, Ja-
pan) with informed consent. Murine alveolar macrophages were obtained
by BAL from 6–8-wk-old ddY male mice. Lungs of mice were subjected to
lavage six times with 1.0 ml saline. Collected cells consisting mostly of
macrophages were suspended in DME containing 5% human serum. Mu-
rine bone marrow cells were obtained from tibiae of 8–12-wk-old C57BL/6
male mice and suspended in  MEM containing 10% FCS.
Immunoblotting
Cells were lysed in lysis buffer containing 1% Brij99, 25 mM Hepes, pH
7.5, 150 mM NaCl, 5 mM MgCl2, 2 mM phenylmethylsulfonyl fluoride, 10
 g/ml aprotinin, and 10  g/ml leupeptin. Samples containing equal pro-
tein concentrations were electrophoresed on SDS-PAGE and transferred to
Immobilon-P membranes (Millipore). The membranes were probed with
mAbs diluted at 1  g/ml, followed by incubation with peroxidase-conju-
gated goat anti–mouse IgG (H L; Bio-Rad Laboratories) diluted 1:2,000.
Immunoreactive bands were visualized with Renaissance
® Chemilumines-
cent Reagent (NEN Life Science Products).
Immunoprecipitation
Lysates containing equal amounts of protein were incubated with anti-inte-
grin and -tetraspanin mAbs. Immune complexes were collected with
protein A-Sepharose (Sigma-Aldrich), separated by SDS-PAGE under non-
reducing conditions, and transferred to an Immobilon-P membrane. Im-
munoblotting was performed with biotinylated mAbs followed by peroxi-
dase-conjugated streptavidin (Zymed Laboratories).
In vitro fusion assay of monocytes, macrophages, 
and bone marrow cells
For human blood monocyte/alveolar macrophage fusion experiments, 2  
10
5 cells were suspended in 100  l culture medium, plated in a 96-well
tissue culture plate (Falcon), and induced to fuse into MGCs by the addi-
tion of 10  g/ml Con A for 3 d. To estimate the degree of cell fusion in the
absence or presence of 10  g/ml mAb or recombinant GST–CD9 protein,
nuclei were visualized using Wright stain. Fusion rates were determined
by calculating the percentages of the number of nuclei within MGCs (three
or more nuclei per cell) per total number of nuclei in six independent
fields. Between 400 and 600 nuclei were counted in each field. For mu-
rine alveolar macrophage fusion, 3   10
5 macrophages were suspended in
50  l DME containing 5% human serum, plated onto a 96-well plate, and
then induced to fuse into MGCs by the addition for 3 d of 10 nM
1 ,25(OH)2D3 and 50  l culture supernatant that was obtained from cul-
tures of Con A–stimulated murine spleen cells. The number of MGCs per
well in triplicate cultures was determined. For murine bone marrow cells,
2   10
6 cells were suspended in 500  l  MEM containing 10% FCS,
plated onto a 24-well plate, and then induced to fuse by the addition for
7 d of 50 ng/ml sRANKL and 20 ng/ml M-CSF. Cells were then fixed and
stained for TRAP (Li et al., 2002). The number of TRAP-positive multinu-
cleated cells (three or more nuclei per cell) per well in triplicate cultures
was determined.
In vivo fusion assay of murine alveolar macrophages
300  g heat-killed and sonicated P. acnes (ATCC 11828; American Type
Culture Collection) was suspended in 100  l PBS and administered in-
tratracheally to CD9 ( / ), CD81 ( / ), and wild-type mice under anes-
thesia as described previously (Itakura et al., 2001). After 7 d, the mice
were killed and lung paraffin sections were prepared to observe MGC for-
mation in the lung. In separate experiments, alveolar macrophages were
isolated by BAL as described above, and the number of MGCs per lung
was determined.
Cell adhesion assay
200,000 monocytes were suspended in 100  l RPMI 1640 containing 10
 g/ml Con A and plated onto the wells of a 96-well tissue culture plate
(Falcon). Cells were then allowed to adhere to the plate for 12 h in the ab-
sence or presence of 10  g/ml mAbs. After nonadherent cells were re-
moved by rinsing, the remaining adherent cells were evaluated in triplicate
cultures using an MTT assay.
Cell aggregation assay
200,000 monocytes were cultured in 100  l RPMI 1640 with 5  g/ml Con
A in the absence or presence of 10  g/ml mAbs for 12 h in wells of a 96-
well nontissue culture-treated plate (Linbro). The number of cell aggregates
( 4 cells/aggregate) was determined in six independent fields.T
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Immunofluorescence
Murine alveolar macrophages were cultured in Lab-Tek
® glass chamber
slides (Nunc), fixed in 3% PFA, and then permeabilized with 0.5% Triton
X-100. Nonspecific recognition of Fc receptors was blocked with 20%
goat serum. The permeabilized cells were stained with 1  g/ml control
mAb (R35–95) or anti–mouse CD9 mAb (KMC8) and incubated with FITC-
conjugated anti–rat immunoglobulin at a 1:50 dilution and 0.5  g/ml pro-
pidium iodide (Sigma-Aldrich). Immunofluorescence images were ob-
tained using an inverted immunofluorescence microscope (Axioplan 2;
Carl Zeiss MicroImaging, Inc.).
Mice
The generation of CD9 ( / ) mice and CD81 ( / ) mice was described
previously (Miyazaki et al., 1997; Miyado et al., 2000). These mice were
backcrossed more than five generations into the C57BL/6 background.
CD9 ( / )/CD81 ( / ) mice were produced by intercrossing CD9 ( / )/
CD81 ( / ) mice. The genotyping of all breeding pairs was confirmed by
PCR analysis. The mice were maintained in a barrier facility, and all ani-
mal procedures were performed in accordance with the Osaka University
(Osaka, Japan) guidelines on Animal Care. 7–11-wk-old mice matched for
age and sex were used in all experiments.
Histological analysis of lung and bone sections
1 ml 10% buffered formaldehyde was instilled into the lung of each mouse
via an intratracheal cannula, and then the whole lung was excised and
fixed in 10% buffered formaldehyde. The fixed lung was embedded in par-
affin, sectioned sagittally, and stained with hematoxylin and eosin. Tibiae
were fixed with ethanol, and the undecalcified bones were embedded in
glycolmethacrylate. 3- m longitudinal sections from the proximal parts
were stained for TRAP. The number of TRAP-positive osteoclasts was de-
termined as described previously (Liu et al., 2001).
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